Tumour marker immunoreactivity in adenocarcinoma.
نویسندگان
چکیده
منابع مشابه
Use of tumour marker immunoreactivity to identify primary site of metastatic cancer.
OBJECTIVES To determine whether variations in the expression of tumour related antigens can predict the origin of tumours. DESIGN Immunohistological study of tumour marker expression in primary adenocarcinomas and respective metastatic deposits. Antibodies to the following tumour markers were used: polymorphic epithelial mucin (NCRC-11 and SM3), carcinoembryonic antigen, carcinoembryonic anti...
متن کاملTumour marker in pancreatic carcinoma
Despite the improved sensitivity of new radiological techniques to detect pancreatic cancer during the last two decades, Warshaw and colleagues [6] have underlined the fact that pre-operative imaging (CT, MRI and Angiography) has a sensitivity of only 78%. As a result, diagnosis is delayed and survival rates ranging from 1% to 5% have remained unchanged, even in resected cases, over the last th...
متن کاملMetastatic prostatic adenocarcinoma-diagnosed by bronchoalveolar lavage and tumour marker determination.
We report a patient who presented with a diffuse interstitial lung disease in whom clinical and radiologic investigation led to the suspicion of lymphangitis carcinomatosa. Bronchoalveolar lavage (BAL) was performed and revealed the presence of prostatic specific antigen (PSA) positive cells. A prostatic needle aspiration confirmed the diagnosis of adenocarcinoma. This case demonstrates the val...
متن کاملCytokeratin immunoreactivity in Ewing sarcoma/ primitive neuroectodermal tumour.
Ewing sarcoma (ES)/ primitive neuroectodermal tumour (PNET) is an aggressive malignant neoplasm affecting mainly children and young adults. The tumour is included with other primitive neoplasms under the category of small round cell tumour. Cytokeratin expression in ES/PNET has been described in sporadic case reports as well as a few systemic series. We studied this feature in Malaysian patient...
متن کاملHER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma
Gastric adenocarcinoma is the second leading cause of death due to cancer in the world and in advanced stages the prognosis is poor with current therapies. Over-expression of HER-2/neu has been seen in several cancers such as gastric cancer and its expression is associated with poor prognosis. The aim of this study is to evaluate the over-expression of HER-2/neu in gastric biopsy samples of pat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Pathology
سال: 1988
ISSN: 0021-9746
DOI: 10.1136/jcp.41.10.1064